SCHEMBL7069587

SCHEMBL7069587

CCCc1ccc(C(c2cc(C=O)ccc2OC)c2cc(C=O)ccc2OC)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.46
TSHR P16473 1/20 0.46
FDPS P14324 1/20 0.44
AOX1 Q06278 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TRIM24 O15164 1/20 0.40
HPGD P15428 1/20 0.40
ALDH5A1 P51649 1/20 0.40
ABAT P80404 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TRIM33 Q9UPN9 1/20 0.40
TACR2 P21452 1/20 0.40
TTR P02766 1/20 0.39
PDCD1 Q15116 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7068044 0.82 ALDH1A1 (0.53) ALDH1A1TSHRFDPSAOX1SMN1; SMN2
SCHEMBL7681882 0.81 ALDH1A1 (0.46) ALDH1A1TSHRAOX1TRIM24HPGD
SCHEMBL7074229 0.80 TTR (0.55) ALDH1A1TSHRFDPSAOX1SMN1; SMN2
SCHEMBL10106384 0.78 ALDH1A1 (0.48) ALDH1A1TSHRFDPSAOX1SMN1; SMN2
SCHEMBL10106357 0.74 ALDH1A1 (0.45) ALDH1A1TSHRFDPSAOX1SMN1; SMN2
SCHEMBL10106362 0.73 ALDH1A1 (0.46) ALDH1A1TSHRFDPSAOX1SMN1; SMN2
SCHEMBL10106328 0.73 ALDH1A1 (0.49) ALDH1A1TSHRFDPSAOX1SMN1; SMN2
SCHEMBL10106350 0.73 ALDH1A1 (0.54) ALDH1A1TSHRFDPSAOX1SMN1; SMN2
SCHEMBL16930085 0.72 ALDH1A1 (0.59) ALDH1A1TSHRFDPSAOX1MAPT
SCHEMBL10106339 0.72 ALDH1A1 (0.47) ALDH1A1TSHRFDPSAOX1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030092685-A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases NITZ THEODORE J (US) 2003-05-15 US disclosed
US-6495580-B1 A BENZYLIDENE DERIVATIVE CONTAINING HETEROCYCLIC RING IS USEFUL AS PNEUMOVIRUS INHIBITOR VIROPHARMA INCORPORATED 2002-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092685-A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases TTPA, HAVCR2, PML ALDH1A1 3369/4885TSHR 4829/4885FDPS 779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.